Tencent completed acquisition of a 15% stake in Insighta from Prenetics for $30m.

Tencent, a Chinese technology conglomerate, completed acquisition of a 15% stake in Insighta, a Hong Kong-based early cancer detection company, from Prenetics, a health sciences company, for $30m. "This investment marks another significant step for Insighta as it continues its mission to transform cancer detection," Danny Yeung, Prenetics CEO.